Page last updated: 2024-11-05

trifluperidol and Brain Damage, Chronic

trifluperidol has been researched along with Brain Damage, Chronic in 2 studies

Trifluperidol: A butyrophenone with general properties similar to those of HALOPERIDOL. It is used in the treatment of PSYCHOSES including MANIA and SCHIZOPHRENIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p621)

Brain Damage, Chronic: A condition characterized by long-standing brain dysfunction or damage, usually of three months duration or longer. Potential etiologies include BRAIN INFARCTION; certain NEURODEGENERATIVE DISORDERS; CRANIOCEREBRAL TRAUMA; ANOXIA, BRAIN; ENCEPHALITIS; certain NEUROTOXICITY SYNDROMES; metabolic disorders (see BRAIN DISEASES, METABOLIC); and other conditions.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Campbell, M1
Fish, B1
Shapiro, T1
Floyd, A1
Le Vann, LJ1

Trials

1 trial available for trifluperidol and Brain Damage, Chronic

ArticleYear
Thiothixene in young disturbed children. A pilot study.
    Archives of general psychiatry, 1970, Volume: 23, Issue:1

    Topics: Brain Damage, Chronic; Child; Child, Preschool; Chlorpromazine; Humans; Intellectual Disability; Sch

1970

Other Studies

1 other study available for trifluperidol and Brain Damage, Chronic

ArticleYear
A new butyrophenone: trifluperidol. A psychiatric evaluation in a pediatric setting.
    Canadian Psychiatric Association journal, 1968, Volume: 13, Issue:3

    Topics: Adolescent; Antidepressive Agents; Aspartate Aminotransferases; Attention; Brain Damage, Chronic; Bu

1968